Algernon Pharmaceuticals Registered (A) Forum: Community User: Support

Hm, sehr schwammige Formulierung, keine Zahlenwerte. Bin nicht sicher wie der Markt reagiert. Scheinbar hat es einen positiven Effekt, ob das jetzt reicht um als Gamechanger gegen Covid wahrgenommenzu werden?

Wann meint Ihr, kann man nachkaufen? Ist ja anscheinend im Moment nicht möglich. Bei 30 Cent je Aktie hat das Thema sicher Potential 🤔

Danke Hanni. Hört sich erstmal gut an. Meine Meinung.

Na dann schauen wir mal wie der Markt das aufnimmt...

by @nasdaq on 15 Dec 2020, 14:16 Algernon Pharmaceuticals Announces Positive Trending Interim Data for its Phase 2b/3 Ifenprodil COVID Study VANCOUVER, British Columbia, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to report, in a descriptive format, positive trending interim data for the Phase 2b part of the Company’s Phase 2b/3 clinical study of Ifenprodil for COVID-19. For the endpoint of ventilation by day 15, there was a trend towards fewer patients requiring mechanical ventilation in the high dose Ifenprodil treatment arm, as compared to patients who were in the untreated arm of the study. Mechanical ventilation is associated with poor prognosis in COVID-19 patients, including increased risk of mortality and procedural complications.(1) In addition, extended duration of mechanical ventilation places an enormous burden on ICUs and entire hospital systems. Although all patients had similar mean WHO and NEWS scores at day 15, there was a trend in the high dose group of Ifenprodil patients to reduce the NEWS score more quickly than control after treatment was initiated. This may suggest that patients are recovering more quickly. If a patient is recovering earlier, it could result in a reduction in the number of days in hospital. A number of other COVID-19 therapeutics have received emergency use authorization from the U.S. FDA based solely on reducing the number of days in hospital. This endpoint was not included in this interim analysis, but will be reported in the final data set. The Company also notes that a review of adverse events indicated that Ifenprodil was generally well tolerated and that no new serious safety concerns have been identified. The majority of adverse events were mild or moderate in severity. A continuous review of safety data is ongoing.  While the Company originally advised that the interim data set would be based on 75 patients, this was increased to up to 123 patients for some of the endpoints owing to the availability of the data. In addition to including full statistics, there will be additional key endpoints reported in the final data set of the Phase 2b part of the study that are not in the interim data set, such as time to discharge from the hospital, and time on mechanical ventilation. The objective of the Phase 2b part of the trial is to inform the Company what the most appropriate endpoint target(s) should be for the Phase 3 part of the study, as well as how many patients would be required to achieve statistical significance. Based on the date the last patient was enrolled in the study, the Company is projecting the final Phase 2b data set will be available in Q1 2021. “While we are very pleased that the interim data has provided us with some positive trending information, we still need to evaluate the full definitive results and statistics to be presented with the final data set,” said Christopher J. Moreau, CEO of Algernon Pharmaceuticals. “We will be especially interested to see the numbers on the overall time spent on ventilation and rate to ventilation to be reported in the final data set.” The Company advises that it is not making any express or implied claims that Ifenprodil has the ability to eliminate, cure or contain COVID-19 (or the SARS-2 Coronavirus) at this time.

Lohnt sich noch ein Einstieg?

Ich warte selber auf News 🙈

Ich hoffe doch noch rein zu kommen bevor es die Ergebnisse gibt😅

Angeblich werden heute die Ergebnisse der Studie veröffentlicht. Andere Aktien die in letzter Zeit positive Studien veröffentlicht haben sind explodiert im wahrsten Sinne des Wortes. Glückwunsch 🍾

Wie kommst Du darauf Elli? Etwas neues gehört? 😃

Hier könnte es die nächsten Tage richtig abgehen

Nein Ellas

Danke Elli dann habe ich ja mein Geld nicht verloren oder ???

Liegt evtl da dran weil der Handel ausgesetzt ist. Da kommen heute die Studienergebnisse

Hallo bin neu hier ... Kann mir jemand sagen was los ist mit algernon Aktie in Börse Stuttgart auf einmal ist mein Geld auf Null... Weiß jemand warum ???

Ja. In etwa. Wie Hanni sagt